A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
暂无分享,去创建一个
H. Mackay | A. Oza | H. Au | J. Wright | T. Alcindor | E. McWhirter | K. Macalpine | Lisa Wang | A. Jarvi | E. Mcwhirter